Coffee with the expert
The Hotez times in Public Health
Summer hit the United States Congress and it’s inferno hot in public health. Coincidentally, we had the privilege to have a candid conversation with Prof. Peter Hotez, M.D., Ph.D., Dean of the National School of Tropical Medicine and Professor of Pediatrics and Molecular Virology & Microbiology at Baylor College of Medicine, who shared his perspectives on many important health issues.
Letter from the editors
Welcome to Vaccines Beat
Dear colleagues, Welcome to the inaugural issue of Vaccines Beat, your go-to source for all updates in vaccinology. Our aim is to provide an innovative and comprehensive global perspective on vaccines, vaccination, vaccine introduction to NIPs;...
News & Alerts
Highlights Issue 001
A summary of the latest News & Alerts in the fields of vaccinology, vaccines, vaccination, and vaccine-preventable diseases. We curate the latest information on regulatory updates, emerging trends, breakthroughs in vaccine technology, vaccine safety and efficacy, global immunization developments and outbreak alerts, as a resource to keep our community informed.
LATEST RELEVANT PUBLICATIONS
Latest published papers and commentaries from the chief editors
Latest impactful scientific publications that stand out for their potential bearing on healthcare. We introduce groundbreaking research findings, innovative treatment modalities, results from phase 1 to 3 vaccine clinical trials, or paradigm-shifting discoveries that redefine our understanding of infectious diseases and therapeutic approaches for all vaccine-preventable diseases.
EDITORS CORNER
Vaccine against Chikungunya: good news, a vaccine has been aproved by the Food and...
Recently, a phase 3 clinical trial published at The Lancet showed high immunogenicity and good safety profile of a one shot of a live attenuated Chikungunya (CHIK) vaccine (1), leading to further look for...
BEST PRACTICE
One dose of Human Papilloma Virus vaccine as a global strategy to prevent...
Even though Human Papilloma Virus (HPV) causes cancer in several epithelia, the priority purpose of HPV massive immunization is the prevention of cervical cancer in women, which accounts for 82% of all HPV-related cancers...
LATEST CLINICAL TRIAL REVIEWS
How new vaccines are developed
The U.S. Food and Drug Administration’s (FDA’s) Center for Biologics Evaluation and Research (CBER) is responsible for regulating vaccine use in the United States. The general stages of vaccine development are: Research and Discovery
Proof of Concept
...
GUEST CONTRIBUTORS
The potential for a new Lyme disease vaccine
Growing need for proactive measures Lyme disease, caused by Borrelia burgdorferi transmitted through infected Ixodes ticks, is the most prevalent vector-borne infectious disease in the Northern hemisphere (1), often leading to long-lasting consequences. The United...